In this week’s View, Dr. Eagle explores the use of high-sensitivity cardiac troponin for risk assessment in patients with chronic coronary artery disease. He then explores the potential of using low-dose colchicine for secondary prevention of coronary artery disease. Finally, Dr. Eagle looks at the use of beta-blockers and heart failure outcomes in patients with mildly reduced or preserved ejection fraction.

Twitter Links:

• Dr. Kim Eagle: @keaglemd
• American College of Cardiology: @ACCinTouch

Clinical Topics: Acute Coronary Syndromes, Cardiac Surgery, Dyslipidemia, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Stable Ischemic Heart Disease, Atherosclerotic Disease (CAD/PAD), ACS and Cardiac Biomarkers, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and SIHD, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Chronic Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and ACS, Interventions and Coronary Artery Disease, Interventions and Imaging, Angiography, Nuclear Imaging, Chronic Angina, Pericardial Disease

Keywords: EaglesEyeView, Acute Coronary Syndrome, Angina, Stable, Biomarkers, Coronary Angiography, Coronary Artery Disease, Myocardial Infarction, Myocardial Ischemia, Myocardial Revascularization, Outpatients, Primary Prevention, Risk Factors, Troponin I, Angina Pectoris, Antihypertensive Agents, Aspirin, Atherosclerosis, Cholesterol, LDL, Colchicine, C-Reactive Protein, Gout, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Inflammation, Interleukin-1, Kidney Diseases, Liver Diseases, Myositis, PCSK9, Percutaneous Coronary Intervention, Proprotein Convertase 9, Renal Insufficiency, Chronic, Secondary Prevention, Stroke, Vascular Diseases, Adrenergic beta-Antagonists, Geriatrics, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Hospitalization, Risk, Stroke Volume, Survival

< Back to Listings